CONSORT of participants with OPV status. by Zahid Hasan Khan (6281396)

“…<div><p>Most vaccinations in the immunization schedule need two or more doses to elicit a protective immune response. Therefore, completion of all doses is crucial for achieving the best possible immunity. …”

Determinants of incomplete vaccination. by Zahid Hasan Khan (6281396)

“…<div><p>Most vaccinations in the immunization schedule need two or more doses to elicit a protective immune response. Therefore, completion of all doses is crucial for achieving the best possible immunity. …”

summary of the confidence intervals. by Yohannis Derbew Molla (16471771)

“…<div><p>Introduction</p><p>Traumatic brain injury (TBI) is a major cause morbidity and mortality globally. …”

PRISMA flowchart of the study selection process. by Yohannis Derbew Molla (16471771)

“…<div><p>Introduction</p><p>Traumatic brain injury (TBI) is a major cause morbidity and mortality globally. …”

All infection data from the study. by Hala Tamim El Jarkass (16625309)

“…We show that infection causes an increase in the level of <i>C. elegans</i> lipid droplet associated lipase, ATGL-1, and a decrease in host fat levels. …”

Difference in (a) IL-17, and (b) TNF-α relative gene expression levels between baseline and six months after treatment using systemic and local antibiotic treatment. by Iva Milinkovic (22331710)

(A–D) Representative immunoblots for the reporter assays shown in Fig 4A–D. by Lorenza Cutrone (21144285)

Overexpression of miR-129-5p alleviated depression-like behaviors by increasing ATP content. by Qiaozhen Qin (13159201)

Overexpression of miR-129-5p alleviated the depressive-like phenotypes of CRS and LPS treated mice. by Qiaozhen Qin (13159201)

PP2B, but not PP1/PP2A, is involved in the NMDA-induced dephosphorylation of pS295. by Takahiko Chimura (729098)

Prime sequences. by Qiaozhen Qin (13159201)

“…Micro RNAs (miRNAs) have been revealed to participate in the pathological process of depression and represent promising therapeutic targets. In this study, we found that microRNA-129-5p (miR-129-5p) was significantly decreased in the brains of depressive mice. …”

Effects of busulfan treatment (6 mg/kg) on the epididymis and sperm of mice over a three-week period. by Lingjun Zhao (21763122)

“…<p>(A) The epididymal sperm concentrations decrease over time and significantly differ between hour 0 (control) and day 21 (<i>n </i>= 3 per group). …”

Mortality of <i>C. maculatus</i> after 24h exposure to GO and GO-GA NPs. by Huda H. Elbehery (22492996)

S1 Data - by Francois Kiemde (5369657)

“…<div><p>Background</p><p>The hormonal shift occurring in pregnant women is crucial for the outcome of pregnancy. We conducted a study in pregnant women living in a malaria endemic area to determine the potential effect of gestational age on the modulation of the endocrine system by cortisol and prolactin production during pregnancy.…”

Characteristic of study population. by Francois Kiemde (5369657)

“…<div><p>Background</p><p>The hormonal shift occurring in pregnant women is crucial for the outcome of pregnancy. We conducted a study in pregnant women living in a malaria endemic area to determine the potential effect of gestational age on the modulation of the endocrine system by cortisol and prolactin production during pregnancy.…”

The performance of eigenvectors of the covariance matrix in a model with more complex population structure. by Joshua G. Schraiber (8027060)

Microstructure of various samples: (a) UT, (b) SP1, (c) SP2, and (d) SP3. by Huashen Guan (20454677)

Ultrafine Particulate Matter Exacerbates the Risk of Delayed Neural Differentiation: Modulation Role of METTL3-Mediated m⁶A Modification by Rui Wang (52434)

“…By employing <i>N</i>6-methyladenosine (m⁶A) methylated RNA immunoprecipitation sequencing and bioinformatics, we identified <i>Zic1</i> as a key target of PM_0.1-induced developmental disturbances. …”

S1 File - A novel yeast-derived aldehyde-reducing compound MF001 protects against alcohol-induced liver damage by Eun-Ho Lee (2696890)

Results for fibrin dominant clots: (A) time to recanalize <i>in vitro</i> model; (B) relative clot reduction; (C) RBC release; (D) relative clot degradation rate. by Sandra Thalerová (11434762)